The reelin pathway is a key contributor to the development of schizophrenia and other neuropsychiatric disorders such as depression and psychosis54,55, and these psychiatric conditions are often comorbid with substance use disorders56,57. The gene discussed is RELN; the disease is depressive symptom measurement.